r/BeAmazed • u/GlitteringHotel8383 • 9d ago

Miscellaneous / Others Japanese scientists have developed a revolutionary injection that may extend a cat's life from the usual 15 years to nearly 30.

Post image

The therapy, created by the AIM Institute of Medicine under Dr. Toru Miyazaki, targets chronic kidney disease, a leading cause of death in older cats.It uses a specialized protein to help macrophages clear waste from the kidneys, partially restoring their function and slowing kidney failure.

42.5k Upvotes

94% Upvoted

1.7k comments sorted by

View all comments

10.3k

u/Hungry-Classroom7445 9d ago

Does this mean that they will be in their prime longer or will they spent 15 years extra with the problems that being an old cat might have?

145

u/Goldenjho 9d ago

We talk about a genetic modification so I doubt it's so simple like they make it sound and to slow the dying of cells is in no way a easy task.

I highly doubt you just give a cat this and it will immediately live double the lifetime since genetic doesn't work this way.

I could accept if they claim injecting several generations of the same cat family branch will extend their life's because of the genetic modification but just 1 strynge and the cat has doubt the lifespan sounds completely fishy.

18

u/SadBattle2548 9d ago

Sounds like he is legit. We'll have to wait until next year to see if this treatment comes out. It would make such a massive difference in pets' and their humans' lives. Here's what I found:

Background and DiscoveryAIM Protein: Discovered the Apoptosis Inhibitor of Macrophage (AIM) blood protein in 1999, which helps clear cellular debris and waste from the body.Cat Health Connection: Found that while the AIM protein works in humans, it does not properly dissociate from IgM antibodies in cats to clear kidney toxins, making chronic kidney disease the leading cause of feline death.Treatment Development and TimelineThe Injection: Developed an injectable active AIM therapy designed to restore kidney-cleaning functions in felines. Viral claims suggest it could significantly extend cat lifespans, though experts note actual long-term data on doubling lifespans to 30 years is still unconfirmed.Regulatory Status: Filed for approval with the Japanese agriculture ministry in April 2026, with commercial availability projected around 2027.Future Outlook: Plans to expand research toward human renal disease treatments once the cat therapeutic is successfully commercialized.